ESSEX BIO-TECH Shares Plunge Following Profit Warning

Stock News07-20 11:16

ESSEX BIO-TECH (HKEX: 01061) shares experienced a significant drop after the company issued a profit warning. At the time of writing, the stock was down 12.89% to HK$2.5, with a turnover of HK$2.43 million.

The decline follows a company announcement made on July 17. ESSEX BIO-TECH stated that for the six-month period ending June 30, 2026, it expects both revenue and profit to decline compared to the same period in 2025. The group anticipates revenue to decrease by approximately 10% and profit to fall by about 30%.

In the corresponding period of 2025, the company reported revenue of around HK$877 million and a profit of approximately HK$163 million. The primary reason cited for the expected decline is an increase in the value-added tax burden borne by the group following the implementation of new VAT laws in China.

Despite these projected headwinds, the company emphasized that it maintains a robust cash flow and financial position sufficient to meet its operational requirements. As of June 30, 2026, the group's cash and cash equivalents stood at approximately HK$807 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment